GC Medical Science Corporation (KOSDAQ:142280)

GC Medical Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	122,190	87,076	77,711	100,562	121,856	152,316
Market Cap Growth	47.74%	12.05%	-22.72%	-17.47%	-20.00%	-53.95%
Enterprise Value	141,277	110,168	105,347	119,151	134,083	193,496
Last Close Price	5620.00	4005.00	3580.00	4770.00	5780.00	7230.00
PE Ratio	38.49	23.75	21.70	55.95	-	-
PS Ratio	1.13	0.80	0.75	1.07	1.08	1.50
PB Ratio	2.64	1.88	1.79	2.72	3.42	4.01
P/TBV Ratio	2.80	2.00	1.92	2.98	3.72	4.27
P/FCF Ratio	49.36	35.17	174.54	-	16.35	-
P/OCF Ratio	16.98	12.10	21.23	23.71	11.20	-
EV/Sales Ratio	1.30	1.02	1.01	1.27	1.19	1.90
EV/EBITDA Ratio	20.72	16.16	17.42	23.25	58.33	-
EV/EBIT Ratio	48.93	38.16	46.60	93.70	-	-
EV/FCF Ratio	57.07	44.50	236.61	-	17.99	-
Debt / Equity Ratio	0.38	0.38	0.40	0.61	0.66	0.98
Debt / EBITDA Ratio	2.56	2.56	2.87	4.41	10.18	-
Debt / FCF Ratio	7.05	7.05	38.98	-	3.14	-
Net Debt / Equity Ratio	0.37	0.37	0.38	0.46	0.36	0.93
Net Debt / EBITDA Ratio	2.51	2.51	2.76	3.29	5.50	-2.15
Net Debt / FCF Ratio	6.90	6.90	37.45	-12.11	1.70	-1.61
Asset Turnover	1.22	1.22	1.16	1.00	1.18	1.01
Inventory Turnover	5.19	5.19	5.35	5.38	4.68	3.78
Quick Ratio	0.61	0.61	0.50	0.58	0.80	0.47
Current Ratio	1.15	1.15	1.06	0.93	1.27	1.07
Return on Equity (ROE)	7.71%	7.71%	8.45%	5.17%	-8.31%	-43.99%
Return on Assets (ROA)	2.02%	2.02%	1.58%	0.85%	-1.18%	-12.53%
Return on Invested Capital (ROIC)	4.40%	4.67%	3.97%	2.49%	-2.98%	-27.85%
Return on Capital Employed (ROCE)	5.20%	5.20%	4.40%	2.90%	-3.20%	-43.10%
Earnings Yield	3.00%	4.21%	4.61%	1.79%	-2.94%	-13.92%
FCF Yield	2.03%	2.84%	0.57%	-1.38%	6.12%	-14.31%
Buyback Yield / Dilution	69.46%	69.46%	-226.38%	-26.96%	-0.05%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.